Daclizumab and pleural effusion Patient Reports February 12, 2012

Daclizumab Side Effects Report #4929106-5
Daclizumab side effect was reported by a Physician from SWITZERLAND on Aug 26, 2005. Male patient, 66 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: constipation , escherichia infection, flatulence, gastrointestinal disorder, ileus paralytic, pleural effusion, pneumonia aspiration, pneumothorax, respiratory depression. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4640131-4
Daclizumab side effect was reported by a Physician from on Apr 11, 2005. Male patient, 56 years of age, was diagnosed with prophylaxis, hyperglycaemia and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: disease recurrence, hepatic haematoma, hepatitis viral, pleural effusion, transaminases abnormal. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, PANTOPRAZOLE, MORPHINE, INSULIN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4649010-X
Daclizumab side effect was reported by a Physician from on Apr 11, 2005. Male patient, 56 years of age, was diagnosed with prophylaxis, hyperglycaemia and was treated with Daclizumab. After drug was administered, patient experienced the following side effects: haematoma, hepatitis viral, pleural effusion, pruritus. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS, PREDNISONE, PANTOPRAZOLE, MORPHINE, INSULIN. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4653623-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, culture positive, neutrophil count increased, oedema peripheral, pleural effusion, renal impairment, skin laceration, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4657902-0
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, escherichia infection, laceration, neutrophil count decreased, oedema peripheral, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4661735-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4662520-4
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, culture positive, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4666052-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, small intestinal haemorrhage, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4674531-3
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites infection, escherichia infection, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.